Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.

Core Insights - Integrated Ventures Inc. has launched a subsidiary, MedWell USA, which has signed a Management Services Organization (MSO) agreement with an FDA licensed pharmaceutical manufacturer [1][2] - MedWell USA will act as a Procurement Agent for Semaglutide, targeting health providers, wellness clinics, and gyms across 23 states [2][4] - The global market for Semaglutide is projected to reach $10.6 billion by 2028, with a compound annual growth rate (CAGR) of 14.5% [3] Company Overview - Integrated Ventures, Inc. is a diversified holdings company based in Safety Harbor, FL, focusing on businesses with high growth potential [7] - Current operations include digital currency mining, MedWell USA as a B2B procurement agency, MedWell Direct for telemedicine services, and MedWell Facilities for real estate opportunities in the health and wellness sector [8] Strategic Focus - MedWell USA aims to enhance access to high-quality Semaglutide and other pharmaceuticals for health and wellness clinics, thereby improving weight management solutions for patients [4][6] - The company plans to expand its offerings to include additional pharmaceuticals and medical supplies, with a focus on building strong relationships within the healthcare industry [6]